BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24726151)

  • 1. Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels.
    Yoo DS; Woo SH; Cho S; Kang SH; Kim SJ; Park SY; Lee SH; Jeon SH; Park J
    Urology; 2014 Jun; 83(6):1339-43. PubMed ID: 24726151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate biopsy in Switzerland: a representative survey on how Swiss urologists do it.
    Leippold T; Preusser S; Engeler D; Inhelder F; Schmid HP
    Scand J Urol Nephrol; 2008; 42(1):18-23. PubMed ID: 17853010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.
    Kobayashi M; Nukui A; Morita T
    Urol Int; 2008; 80(2):186-92. PubMed ID: 18362491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
    Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
    Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can antibiotic treatment exclude inflammation in the differential diagnosis of elevated PSA?].
    Liu J; Hu WL
    Zhonghua Nan Ke Xue; 2012 Aug; 18(8):747-50. PubMed ID: 22934524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.
    Hochreiter WW
    Andrologia; 2008 Apr; 40(2):130-3. PubMed ID: 18336465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in Victoria in 1993: patterns of reported management.
    Frydenberg M; Giles GG; Mameghan H; Thursfield VJ; Millar J; Wheelahan JB; Bolton DM; Syme RR
    Med J Aust; 2000 Mar; 172(6):270-4. PubMed ID: 10860092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA.
    Heldwein FL; Teloken PE; Hartmann AA; Rhoden EL; Teloken C
    BJU Int; 2011 May; 107(10):1576-81. PubMed ID: 21244610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
    Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
    J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing practices for chronic prostatitis: a nationwide survey of urologists in South Korea.
    Ku JH; Paick JS; Kim SW
    Int J Urol; 2005 Nov; 12(11):976-83. PubMed ID: 16351654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of delayed clinician response to elevated prostate-specific antigen values.
    Nepple KG; Joudi FN; Hillis SL; Wahls TL
    Mayo Clin Proc; 2008 Apr; 83(4):439-45. PubMed ID: 18380989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA).
    Loeb S; Gashti SN; Catalona WJ
    Urol Oncol; 2009; 27(1):64-6. PubMed ID: 19111800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population.
    Wallner LP; Frencher SK; Hsu JW; Chao CR; Nichol MB; Loo RK; Jacobsen SJ
    BJU Int; 2013 Jun; 111(8):1245-52. PubMed ID: 23320750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.